Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
09 June, 2025•10 min
0
09 June, 2025•10 min
0
More in Business
Business
WeWork India: the IPO that could have been so much more
The co-working giant’s initial public offering is a missed opportunity that prioritizes promoter interests at the expense of incoming shareholders. Given this, the tepid investor interest is no surprise.
You may also like
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
Business
News explainers that stood out in 2024
Bluesky vs X, the UAE deluge, Adar Poonawalla’s investment in Karan Johar’s Dharma Productions and more.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
